Affiliation:
1. Endocrine Hypertension Research Centre, University of Queensland School of Medicine, Princess Alexandra and Greenslopes Hospitals, Brisbane, Queensland 4102, Australia
Abstract
Abstract
Corticosteroid excess is associated with adverse cardiovascular outcomes. Patients with Cushings's syndrome, either caused by endogenous or exogenous glucocorticoid excess, and patients with primary aldosteronism have increased cardiovascular risk. The increase in risk is mediated partly by traditional cardiovascular risk factors including hypertension and metabolic syndrome but also by other, less well-characterized mechanisms. Experimental and human studies have shown that target organ deterioration induced by aldosterone depends on concomitant high dietary salt intake. Key ongoing research questions that warrant further study by both clinical and experimental approaches include the following: 1) beyond inducing the metabolic syndrome, what are the mechanisms by which glucocorticoids are associated with excess cardiovascular risk, 2) what are the cellular pathways by which excessive mineralocorticoid receptor activation brings about cardiovascular and renal damage, and 3) why is salt critical in this process?
Reference52 articles.
1. The natural history of Cushing's syndrome.;Plotz;Am J Med,1952
2. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.;Magiakou;N Engl J Med,1994
3. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.;Williamson;J Hypertens Suppl,1996
4. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man.;Connell;J Hypertens,1987
5. Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man.;Whitworth;Clin Exp Hypertens A,1984
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献